Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Net Profit Margin

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in Percent.

The item "Net-Profit-Margin" stands at 34.75 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Net Profit Margin" stands at 34.75 Percent. This represents an increase of 30.21 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 116.31 compared to the value the year prior.
The Serie's long term average value is -24.61 percent. It's latest available value, on 09/30/2025, is 59.36 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +134.88 .
The Serie's change in percentage points from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0.

Net Profit Margin for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Profit Margin905,699,262,464.00
LogoJohnson & Johnson - Net Profit Margin486,508,953,600.00
LogoAbbVie Inc - Net Profit Margin399,570,305,024.00
LogoRoche Holding AG - Net Profit Margin317,433,206,677.55
LogoAstraZeneca PLC - Net Profit Margin280,205,508,085.11